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Acetylation1,2, phosphorylation3 and methylation4 of the amino-
terminal tails of histones are thought to be involved in the
regulation of chromatin structure and function5–7. With just
one exception8,9, the enzymes identified in the methylation of
specific lysine residues on histones (histone methyltransferases)
belong to the SET family10. The high-resolution crystal structure
of a ternary complex of human SET7/9 with a histone peptide and
cofactor reveals that the peptide substrate and cofactor bind on
opposite surfaces of the enzyme. The target lysine accesses the
active site of the enzyme and the S-adenosyl-L-methionine
(AdoMet) cofactor by inserting its side chain into a narrow
channel that runs through the enzyme, connecting the two
surfaces. Here we show from the structure and from solution
studies that SET7/9, unlike most other SET proteins, is exclu-
sively a mono-methylase. The structure indicates the molecular
basis of the specificity of the enzyme for the histone target, and
allows us to propose a model for the methylation reaction that
accounts for the role of many of the residues that are invariant
across the SET family.
Many SET proteins have now been characterized biochemically
and several have been the subject of X-ray structure analysis: SET7/9
from human11 and its complex with the product S-adenosyl-L-
homocysteine (AdoHcy)12; Dim-5 from Neurospora crassa6; Rubisco
large subunit methyltransferase (LSMT) from pea with AdoHcy13;
and Clr4 from Schizosaccharomyces pombe14. SET proteins can be
classified according to the lysine residues that they target on
histones H3, H4 and H2A4, and it is apparent that methylation at
these different sites gives rise to distinct biological effects. An
additional level of complexity is that lysine residues may be
mono-, di- or tri-methylated and that these distinct species lead
to different signalling events. For example, in Saccharomyces cere-
visiae, although di-methylation of Lys 4 on histone H3 is present at
both active and inactive euchromatic genes, tri-methylation is
linked exclusively to active genes15.
NMR studies (see Supplementary Information) indicated that a
histone peptide containing mono-methylated Lys 4 was better
ordered in complex with SET7/9 than unmodified peptide. We
therefore used the products of the normal histone methyltransferase
(HMT) reaction for crystallization experiments (methylated lysine
peptide and AdoHcy). In our previous studies11 we obtained useful
SET7/9 crystals only from constructs lacking the small carboxy-
terminal segment, which is, nevertheless, essential for the catalytic
activity of the enzyme. Here, we have used a catalytically active
construct that contains the complete C-terminal segment. We
obtained well-ordered crystals of the ternary complex of SET7/9
that diffracted to at least 1.7 A˚ spacing, and the structure was readily
solved by molecular replacement. The C-terminal segment, the
AdoHcy cofactor and most of the substrate peptide are well defined
in the electron density maps, as are all the important residues
around the active site. The overall structure of the ternary complex
Figure 1 Structure of the SET7/9 ternary complex. a, Two orthogonal views of the SET7/9
ternary complex in ribbons representation. The N-terminal domain is coloured pink, the
SET domain is blue and the C-terminal segment is grey. The H3 peptide is indicated in
green, with the side chain of methylated Lys 4 shown. The S-adenosyl-L-homocysteine
(AdoHcy) cofactor is coloured yellow. The secondary structure elements are labelled
according to our earlier structure. Two small turns of the 310 helix are also labelled. b, Two
views of the SET domain are shown in a surface representation coloured according to
electrostatic potential (the two views are related by a twofold rotation about a vertical axis).
The left panel shows AdoHcy coloured yellow; the right panel shows the H3 peptide
coloured green. The inset panel shows a close-up view of the lysine access channel
containing the methyl lysine side chain as viewed from the S-adenosyl-L-methionine
(AdoMet)-binding site.
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of SET7/9 is shown in Fig. 1 (see Supplementary Information for
crystallographic statistics).
The most notable feature of the catalytic structure is that the
AdoHcy and the peptide substrate are located on opposite sides of
the SET domain and that there is a narrow channel passing through
the enzyme that connects the peptide and cofactor binding surfaces.
The target lysine residue of the substrate (Lys 4) is inserted into this
channel so that its amine can access the methyl donor (AdoMet; see
Fig. 1b). The packing of the C-terminal segment against the SET
domain is required to form the lysine access channel, which explains
why this feature has not been observed in previous HMTase
structures (although it was noted in the context of Rubisco LSMT,
as was the presence of a molecule of HEPES in the channel)13. The
C-terminal segment (residues 345–366) is organized into two
structural features. Residues 337–349, belonging mainly to the
SET domain, form an approximate b-hairpin structure that
protrudes at a right angle to the surface of the enzyme. This is
followed by three residues that accommodate a sharp bend in the
polypeptide chain before the final stretch of the protein that adopts
an a-helical conformation (Fig. 1a). Tyr 335 and Tyr 337, located
Figure 2 Active site of SET7/9. a, Stereographic representation of selected active-site
residues together with methylated Lys 4 (MeLys 4), AdoHcy and several main-chain
carbonyl groups oriented towards the lysine amine. b, Electron density (2F o 2 F c)
covering part of the active site; the view is in the same orientation as in a. c, Schematic
diagram of the reaction. The structure shows that the lysine has been stripped of all
solvent molecules except for the one water used as a hydrogen-bond acceptor to orient
the amino group. This desolvation will lower the pK a of the lysine amino group and also
enhance its nucleophilicity. At the same time, the local orientation of the dipoles of main-
chain carbonyl groups towards the nitrogen will stabilize the developing positive charge on
that atom as the methylation reaction proceeds. There is no proximate proton acceptor to
provide general base catalysis for the nucleophilic nitrogen. Mechanistically, it seems
probable that the lysine side chain enters the active site with difficulty in its protonated
form, the passage of this cation through the channel being facilitated by the faces of the
flanking tyrosines. In the active site, the desolvated lysine is deprotonated, possibly to one
of the flanking tyrosine oxygens. Thereafter the methylation reaction proceeds without
general base catalysis, facilitated simply by alignment of orbitals, by desolvation, and by
stabilization of charge reorganization.
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just before the C segment, are both important for the formation of
the lysine access channel. The arrangement of the b-hairpin is such
that it stabilizes the conformation of these two tyrosine residues
while also contributing to one of the sides of the groove into which
the peptide binds. The second side of the peptide-binding groove is
made up by residues 255–268 (including b-17). The a-helix at the
end of the C-terminal segment packs against b-19, particularly
Phe 299 (located just beyond the conserved NHS signature motif)16,
and makes hydrophobic packing interactions with the AdoHcy
cofactor through Trp 352.
From the high-resolution structure presented here, and from the
previous co-crystal structures of Rubsico LSMT/AdoHcy13 and
SET7/AdoHcy12, it is apparent that in our earlier studies the
orientation of AdoMet, which we modelled into a low-resolution
difference map, was incorrect. The mode of cofactor binding in our
present structure is essentially identical to that described pre-
viously12,13. In this alignment, the methyl group to be transferred
from the AdoMet to the amine is pointing into the lysine-binding
channel (see Fig. 2a). At the peptide-binding site, the channel
surface is largely made up by the side chains of Leu 267 and Tyr
residues 305, 335 and 337 (Fig. 2a). The alkyl component of the
lysine side-chain therefore inhabits a hydrophobic environment.
The other end of the channel, where it opens onto the cofactor-
binding surface, is dominated by four tyrosine OH groups (Tyr 245,
305, 335, 337) and five main-chain carbonyl groups, all approxi-
mately oriented towards the lysine amine group. There are also
several well-defined water molecules in the vicinity of the active site,
although only one is close to the lysine amine. The structure, with its
catalytic and binding surfaces, explains the role of a number of
invariant residues whose mutation to alanine has been shown to
abolish HMTase activity without significantly affecting the affinity
for substrate or cofactor binding. The aromatic ring of Tyr 335
forms a significant part of the binding cavity for the alkyl portion of
the Lys 4PEP residue (histone peptide substrate) while its side-chain
oxygen makes a single hydrogen bond to the main-chain carbonyl of
residue 295. The importance of the correct positioning of this
tyrosine residue is underscored by the observation that His 297
(of the NHS signature) acts to stabilize its conformation by acting as
a hydrogen-bond acceptor to its main-chain amide (Fig. 2a).
The electron density for the methyl Lys 4PEP is very well defined
and clearly shows the location of the single methyl group (Fig. 2b).
Examination of the active site also reveals that the lysine amine
        30 min
        60 min
Figure 3 Activity of SET7/9. a, Analysis of methylation reaction products. The left-hand
panels are for SET7/9; the right-hand panels are for G9a. The upper panel shows
methylation of an H3 peptide at various time intervals as resolved by high-performance
liquid chromatography (HPLC). The middle and lower panels show representative matrix-
assisted laser desorption/ionization–time-of-flight (MALDI–TOF) analysis of fractions
collected from the HPLC. Examples are from fraction points 1 and 2, respectively. A 210,
absorbance at 210 nm; a.i., arbitrary intensity. b, Histone methyltransferase assay of
SET7/9 and the point mutations Y245A and Y245F, with H3 peptide as substrate either
unmodified, mono- or di-methylated at Lys 4.
Figure 4 Peptide interactions with SET7/9. a, Schematic representation of interactions
made by the histone H3 peptide in complex with SET7/9. The positions of residues
beyond the 1 position are not shown because they are affected by lattice contacts.
b, Sequences of histones subject to methylation, aligned according to the position of their
target lysine residues. Basic residues are highlighted in red.
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donates hydrogen bonds to both the invariant Tyr 245 and to a
tightly bound water molecule (W1). We are confident that the lysine
is acting as a hydrogen-bond donor in both cases because of the
nature of the other hydrogen bonds made by Tyr 245 and W1
(Fig. 2a). The orientation of the lysine amine group is such that the
amine-methyl bond is aligned towards the sulphur atom of the
AdoHcy. Moreover, it is directed at sulphur along the tetrahedral
vector corresponding to the (S)-location of the methyl group in
AdoMet17. In other words, the geometry is exactly that expected for
the trajectory of the methylation reaction and this feature will
provide an important entropic contribution towards enzyme-
mediated catalysis (Fig. 2c).
Our previous data11 suggested that SET7/9 could not use mono-
methyl Lys 4 peptide as a substrate for further methylation. Thus we
have further analysed the methylation reaction. Reaction mixtures
were set up with unmodified peptide and AdoMet, and conditions
found where the reaction was driven essentially to completion. As
shown in Fig. 3a, high-performance liquid chromatography
(HPLC) separation of the reaction products resulted in a peak
that eluted at a different position to the unmodified peptide, and
matrix-assisted laser desorption/ionization (MALDI) analysis of
this material revealed only mono-methylated peptide. Taken with
our previous data, these results support the conclusion that SET7/9
catalyses the addition of a single methyl group to its target lysine.
The reason for SET7/9 acting as a mono-methyltransferase is
apparent from our crystal structure. The peptide used for crystal-
lization was synthesized using mono-methylated lysine at position
4. In the crystal structure there is well-defined electron density for
this methyl group in just one position. The arrangement of the two
hydrogen-bond acceptor groups (for the lysine amine) provides an
immediate explanation for the lack of rotation about the CE–NZ
bond; Tyr 245 and W1 not only make favourable interactions that
stabilize the observed rotamer, but they also preclude, on steric
grounds, a methyl group in either of the two other positions that
would orient a lone pair of electrons on the lysine nitrogen towards
the sulphur of the AdoMet. Thus the structure shows that the
arrangement of protein side chains and, indirectly, water molecules
at the active site of SET7/9 is such that it can only catalyse the
addition of a single methyl group to the lysine amine.
Inspection of the sequence of other SET proteins4 near the active
site suggests why many of these enzymes catalyse di- or tri-
methylation of their target lysines. Only Tyr 245 and Tyr 335 are
considered invariant across the SET family, many other residues are
highly variable. So, for example, Tyr 305 is substituted for a valine
residue in SUV39H1 (a tri-methylase) and a proline in G9a (a di-
methylase). Both of these substitutions would seem likely to
produce a cavity at the active site that could accommodate a methyl
substituent on the lysine amine. We have previously reported that
the Y245A mutation in SET7/9 leads to a marked reduction in
HMTase activity11. We now show that although this mutant has
greatly reduced activity with respect to an unmodified lysine
substrate, it has substantial activity if assayed with mono- or with
di-methylated Lys 4 substrate (Fig. 3b). Thus, Y245A is able to
convert mono-methylated substrate to tri-methylated product. The
structure readily provides a rationale for these observations. The
chemistry of methyl transfer dictates that for di- and then for tri-
substitution to occur, the existing methyl groups on the lysine
would first have to be positioned approximately either at the OH of
Tyr 245 or W1 sites, and finally in both of these positions. Removal
of the aromatic ring of Tyr 245 creates a site for the first attached
methyl group, thus enabling a second addition. The fact that the
mutant enzyme can generate tri-methylated lysine further implies
that the Y245A mutation also disrupts the local structure, so that
W1 is displaced, allowing di-methylated lysine to bind appropri-
ately for a third methylation.
The histone peptide binds in a largely extended conformation
into a shallow groove, as shown in Fig. 1b. The binding is mediated
by a network of hydrogen bonds and salt bridges, involving both the
main chain and side chains of the peptide (Fig. 4a). The target
Lys 4PEP residue is located approximately at the centre of the defined
peptide, and the interactions of non-conserved SET7/9 residues
with the peptide seems to account for the enzyme’s specificity.
Arg(22)PEP (residues are numbered relative to the target lysine)
forms a hydrogen bond with the main-chain carbonyl of residue
258, such that the alkyl component of its side chain packs against the
face of Trp 260. Thr(21)PEP forms a hydrogen bond with Ser 268,
and Gln(1)PEP forms a hydrogen bond with the side chain of
Lys 317. Arg(22)PEP therefore seems to have a particularly import-
ant role in mediating substrate specificity. Moreover, inspection of
the various histone target sequences (Fig. 4b) shows that only the
Lys 4 site of histone H3 contains a basic residue in the 22 position.
The other histone target sites all have a basic residue either at the 21
or 1 position. Both activity measurements11 and peptide affinity
measurements, using a peptide in which Arg(22)PEP is mutated to
an alanine (data not shown), support the hypothesis that this
arginine residue contributes significantly to peptide binding to
SET7/9. It seems that the structure of the ternary complex of
SET7/9 presented here will provide a good model for assessing the
probable substrate specificity of other SET proteins from their
primary sequence. A
Methods
Protein constructs
DSET7/9 (residues 52–366) and G9a (621–1000) were expressed as glutathione
S-transferase (GST) fusions in pGEX 6P1 in Escherichia coli BL21. The GST was removed
by overnight treatment with PreScission Protease (Amersham) before gel filtration.
Preparation of DSET7/9 in D2O for NMR studies resulted in a series of N-terminal
degradation products that remained catalytically active. Subsequently, DDSET7/9
(108–366) was prepared as above and found to be stable for growth in D2O, and was
consequently used for further NMR and crystallography experiments. Site-directed
alanine mutations were introduced using the Stratagene Quikchange mutagenesis kit, and
mutations were confirmed by DNA sequencing and electrospray mass spectrometry.
Synthetic peptides were prepared by W. Mawby, and AdoHcy was obtained from Fluka.
Crystallography
Protein stock solution was prepared at 100 mg ml21 in 50 mM Tris, pH 7.0, 100 mM NaCl,
and then incubated with a twofold molar excess of mono-methylated Lys 4 ten-residue
peptide and AdoHcy. Crystals were grown by vapour diffusion at room temperature as
hanging drops. Drops were prepared by mixing equal volumes of protein complex with
reservoir solution containing 0.1 M Tris, pH 7.8, and 22% PEG 3350. Crystals were first
transferred into mother liquor augmented with an additional 5% PEG 400, before
plunging into liquid nitrogen. Data were collected from flash-cooled crystals at 100K on a
Raxis-II detector mounted on a Rigaku RU200 generator. Diffraction data were integrated
and scaled using DENZO and SCALEPACK18. The structure was solved by molecular
replacement using our previous model (1H3I.brk) with AMORE. Subsequent refinement
was carried out using REFMAC519 and manual model building in O20.
NMR
NMR spectra were recorded at 25 8C on Varian Inova spectrometers operating at 1H
frequencies of 600 MHz and 800 MHz. Protein samples (approximately 0.5 mM) were
prepared in 50 mM Tris-HCl, 0.5 mM Tris(2-carboxyethyl)phosphine hydrochloride, 10%
D2O, pH 6.5.
HMTase activity measurements
The methyltransferase activity of SET7/9 and mutant constructs described in the text were
determined in a reaction volume of 20 ml containing 3 mM AdoMet supplemented with
[methyl-3H]AdoMet (4 mCi) (Amersham) and 750 nM purified methylase in reaction
buffer (50 mM Tris, pH 8.5, 100 mM NaCl, 1 mM EDTA, 1 mM dithiothreitol (DTT)) with
50 mM histone peptide. After incubation at 37 8C for 60 min the reaction was vacuum-
blotted onto membrane (Hybond-C; Amersham), washed, and the activity was measured
by scintillation counting.
Analytical analysis of histone methylation
The histone methyltransferase assay was carried out at 37 8C in 50 mM Tris-HCl, pH 8.0,
100 mM NaCl, 1 mM DTT, with 300 mM AdoMet (Fluka), 100 mM H3 peptide
(ARTKQTARKSTGGKAPRKQY), 1.5 mM enzyme. At the time intervals indicated, an
aliquot of the reaction was removed and quenched in 8 M urea and acidified with glacial
acetic acid. The reaction products was separated by reverse-phase HPLC (Jasco) on a
Zorbax 300SB-C18 column (Rockland Technologies) using a gradient from 0% to 40%
acetonitrile in the presence of 0.05% trifluoroacetic acid at 55 8C. Fractions from the
peptide peak were analysed using a Reflex III MALDI–time-of-flight mass spectrometer
(Bruker Daltonik) to obtain positive ion mass spectra.
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The neutrality test equation applied in this Letter F 
Nej2GB=h2j2GWt was incorrect: the correct equation is F 
Nej2GB=j2GWt: Consequently, the numbers in the right three
columns of the original Table 1 are wrong (corrected below). In
addition, some variance estimates in Table 1 and some values of
Fig. 2 were reported incorrectly (the entire correct Table 1 and the
correct Fig. 2 are available from the authors). These errors do not
affect our conclusion that the populations evolved predominantly
as a result of natural selection. We thank W. G. Hill for bringing
these errors to our attention. A
Table 1
Trait Pairwise comparison F1, 1 P Ne (sign)
.............................................................................................................................................................................
Length at termination (mm) Les–Ht 37.7 *** 2.5
Les–Aur 0.78 0.38 272
Ht–Aur 8.63 ** 17.7
Yolk-sac volume (mm3) Les–Ht 29.0 *** 3.21
Les–Aur 59.2 *** 3.59
Ht–Aur 3.17 0.07 48.3
Growth rate (mm/DD) Les–Ht 20.5 *** 4.55
Les–Aur 6.31 ** 33.7
Ht–Aur 41.5 *** 3.68
Survival (%) Les–Ht 5.90 * 15.8
Les–Aur 3.13 0.08 68.0
Ht–Aur 1.20 0.27 128
Incubation time (days) Les–Ht 4.02 * 23.1
Les–Aur 1.56 £ 1027 .0.99 1.36 £ 109
Ht–Aur 7.82 ** 19.5
Swim-up length (mm) Les–Ht 0.26 0.61 363
Les–Aur 0.04 0.84 5.79 £ 103
Ht–Aur 2.73 £ 1028 .0.99 5.60 £ 109
Hatching length (mm) Les–Ht 1.46 £ 1028 .0.99 6.38 £ 109
Les–Aur 0.78 0.38 274
Ht–Aur 2.16 £ 1028 .0.99 7.07 £ 109
.............................................................................................................................................................................
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